Lauren Tyler Purchases 550 Shares of Cencora (NYSE:COR) Stock

Cencora, Inc. (NYSE:COR) Director Lauren Tyler purchased 550 shares of the business’s stock in a transaction dated Monday, June 22nd. The shares were purchased at an average cost of $270.23 per share, with a total value of $148,626.50. Following the acquisition, the director owned 4,359 shares in the company, valued at $1,177,932.57. This trade represents a 14.44% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link.

Cencora Stock Performance

Shares of NYSE:COR opened at $287.55 on Friday. Cencora, Inc. has a 1 year low of $244.82 and a 1 year high of $377.54. The stock has a market capitalization of $55.95 billion, a price-to-earnings ratio of 22.05, a price-to-earnings-growth ratio of 1.53 and a beta of 0.59. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59. The company’s 50 day simple moving average is $281.44 and its 200 day simple moving average is $322.43.

Cencora (NYSE:COR) last released its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing the consensus estimate of $4.82 by ($0.07). Cencora had a return on equity of 135.20% and a net margin of 0.78%.The business had revenue of $78.36 billion for the quarter, compared to the consensus estimate of $81.09 billion. During the same quarter in the previous year, the company earned $4.42 earnings per share. The firm’s revenue for the quarter was up 3.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, research analysts predict that Cencora, Inc. will post 17.79 EPS for the current fiscal year.

Cencora announced that its board has authorized a stock repurchase plan on Thursday, May 21st that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the company to purchase up to 3.9% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s leadership believes its stock is undervalued.

Cencora Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were paid a $0.60 dividend. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 annualized dividend and a yield of 0.8%. Cencora’s dividend payout ratio (DPR) is 18.40%.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on COR. Citigroup dropped their target price on shares of Cencora from $405.00 to $355.00 and set a “buy” rating for the company in a report on Thursday, May 7th. Bank of America lifted their price target on shares of Cencora from $280.00 to $285.00 and gave the company a “neutral” rating in a report on Wednesday. UBS Group upped their price objective on shares of Cencora from $410.00 to $412.00 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Weiss Ratings downgraded shares of Cencora from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, May 22nd. Finally, Wells Fargo & Company decreased their target price on shares of Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a research note on Monday, May 11th. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $367.75.

Institutional Trading of Cencora

A number of hedge funds have recently made changes to their positions in the company. AustralianSuper Pty Ltd acquired a new stake in Cencora during the third quarter worth approximately $26,191,000. Chilton Investment Co. Inc. acquired a new position in Cencora in the third quarter valued at approximately $459,000. Nordea Investment Management AB boosted its holdings in shares of Cencora by 3.8% during the 4th quarter. Nordea Investment Management AB now owns 1,256,356 shares of the company’s stock worth $426,715,000 after buying an additional 45,712 shares in the last quarter. Groupama Asset Managment bought a new position in shares of Cencora during the 3rd quarter worth approximately $1,225,000. Finally, Assetmark Inc. grew its position in shares of Cencora by 57.0% during the 4th quarter. Assetmark Inc. now owns 67,281 shares of the company’s stock worth $22,724,000 after buying an additional 24,431 shares during the period. 97.52% of the stock is owned by institutional investors and hedge funds.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.